Patient Pathfinder: Clinical Trials
Clinical Trials for Non Hodgkin Lymphoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 512 active Non Hodgkin Lymphoma trials
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Study Evaluating SC262 in Subjects With r/r Non-Hodgkin’s Lymphoma (VIVID)
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
There are 512 active Non Hodgkin Lymphoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowPlease confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.